Class A is no solution to the problem of 'monkey dust'
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
Are the neurocognitive deficits associated with MDMA caused by statistical deficits in ecstasy research? A systematic review
A tale of two moralities: Politicians, doctors, use of addictive substances and lobbying
Harm Reduction in Public Policy - the UK and the US – A DrugScience evening reception at the House of Lords
Addiction: from basic neuroscience to clinical treatments
Pharmacies as potential providers of harm reduction services: A preliminary online survey
The early use of MDMA (‘Ecstasy’) in psychotherapy (1977–1985)
New analysis of alcohol and cannabis – what’s the harm?
Substance misuse-related poisoning deaths, England and Wales, 1993–2016
A multi-criterion decision analysis applied to alcohol and cannabis regulation
An effective hangover treatment: Friend or foe?
My dead daughter's shoes
No laughing matter: how the anti-nitrous oxide campaign is a waste of time and money
A fentanyl future?
Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policy
Specific harm reduction strategies employed by MDMA/ecstasy users in the United States and the United Kingdom
WHO and UNDP change in leadership: What views on drug policy and harm reduction?
Recreational MDMA testing - a European perspective
THCv - an abject cop-out from the ACMD, another research opportunity for the UK lost
How the law against synthetic cannabinoids might destroy pharmaceutical discovery in the UK
The 15th anniversary of the Portuguese drug policy: Its history, its success and its future
Constructing drug effects: A history of set and setting
Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future
‘Scotch mist’: the ongoing saga of Alcohol Minimum Unit Pricing